🚀 VC round data is live in beta, check it out!
Genomed Valuation Multiples
Discover revenue and EBITDA valuation multiples for Genomed and similar public comparables like Synthetic MR, Biomaxima, Prostatype Genomics, Brainscan and more.
Genomed Overview
About Genomed
Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.
Founded
2008
HQ
Employees
35
Website
Financials (FY)
EV
$8M
Genomed Financials
Genomed reported last fiscal year revenue of $8M and EBITDA of $1M.
In the same fiscal year, Genomed generated $5M in gross profit, $1M in EBITDA, and $935K in net income.
Genomed P&L
In the most recent fiscal year, Genomed reported revenue of $8M and EBITDA of $1M.
Genomed expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $8M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $5M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 66% | XXX | XXX | XXX |
| EBITDA | — | XXX | $1M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 14% | XXX | XXX | XXX |
| Net Profit | — | XXX | $935K | XXX | XXX | XXX |
| Net Margin | — | XXX | 12% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Genomed Stock Performance
Genomed has current market cap of $10M, and enterprise value of $8M.
Market Cap Evolution
Genomed's stock price is $7.35.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $10M | 0.1% | XXX | XXX | XXX | $0.71 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGenomed Valuation Multiples
Genomed trades at 1.0x EV/Revenue multiple, and 5.9x EV/EBITDA.
Genomed Financial Valuation Multiples
As of April 20, 2026, Genomed has market cap of $10M and EV of $8M.
Equity research analysts estimate Genomed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Genomed has a P/E ratio of 10.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $10M | XXX | $10M | XXX | XXX | XXX |
| EV (current) | $8M | XXX | $8M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 5.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 7.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.5x | XXX | XXX | XXX |
| P/E | — | XXX | 10.4x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 14.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Genomed Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Genomed Margins & Growth Rates
Genomed's revenue in the last fiscal year grew by 27%.
Genomed's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Genomed Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 27% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 150% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 52% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Genomed Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Genomed | XXX | XXX | XXX | XXX | XXX | XXX |
| Synthetic MR | XXX | XXX | XXX | XXX | XXX | XXX |
| Biomaxima | XXX | XXX | XXX | XXX | XXX | XXX |
| Prostatype Genomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Brainscan | XXX | XXX | XXX | XXX | XXX | XXX |
| Predilife | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Genomed M&A Activity
Genomed acquired XXX companies to date.
Last acquisition by Genomed was on XXXXXXXX, XXXXX. Genomed acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Genomed
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGenomed Investment Activity
Genomed invested in XXX companies to date.
Genomed made its latest investment on XXXXXXXX, XXXXX. Genomed invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Genomed
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Genomed
| When was Genomed founded? | Genomed was founded in 2008. |
| Where is Genomed headquartered? | Genomed is headquartered in Poland. |
| How many employees does Genomed have? | As of today, Genomed has over 35 employees. |
| Is Genomed publicly listed? | Yes, Genomed is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Genomed? | Genomed trades under GEN ticker. |
| When did Genomed go public? | Genomed went public in 2011. |
| Who are competitors of Genomed? | Genomed main competitors are Synthetic MR, Biomaxima, Prostatype Genomics, Brainscan. |
| What is the current market cap of Genomed? | Genomed's current market cap is $10M. |
| What is the current revenue of Genomed? | Genomed's last fiscal year revenue is $8M. |
| What is the current EV/Revenue multiple of Genomed? | Current revenue multiple of Genomed is 1.0x. |
| Is Genomed profitable? | No, Genomed is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.